1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. Key Findings of the Study
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. North American Nuclear Medicine Market Forecast by Applications (US$ Billion)
5.1. Introduction
5.2. SPECT Market
5.3. PET Market
6. North American Nuclear Medicine Market Forecast by Procedures (US$ Billion)
6.1. Introduction
6.2. Central Nervous System
6.3. Endocrine
6.4. Skeletal
6.5. Gastrointestinal
6.6. Genito-urinary
6.7. Pulmonary
7. North American Nuclear Medicine Market Forecast by End-User Industry (US$ Billion)
7.1. Introduction
7.2. Hospitals
7.3. Diagnostic centers
7.4. Research Institutes
8. North American Nuclear Medicine Market Forecast by Geography (US$ Billion)
8.1. Introduction
8.2. North America
8.2.1. US
8.2.2. Mexico
8.2.3. Canada
8.2.4. Others
9. Competitive Intelligence
9.1. Strategies of Key Players
9.2. Recent Investments and Deals
10. Company Profiles
10.1. Introduction
10.2. Bracco
10.2.1. Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Key Developments
10.3. Cambridge Isotope Laboratories, Inc.
10.3.1. Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Key Developments
10.4. Cardinal Health
10.4.1. Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Key Developments
10.5. Fujifilm Holdings Corporation
10.5.1. Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Key Developments
10.6. GE Healthcare (Subsidiary of General Electric Company)
10.6.1. Overview
10.6.2. Financials
10.6.3. Products and Services
10.6.4. Key Developments
10.7. Nordion, Inc.
10.7.1. Overview
10.7.2. Financials
10.7.3. Products and Services
10.7.4. Key Developments
10.8. Taiyo Nippon Sanso Corporation
10.8.1. Overview
10.8.2. Financials
10.8.3. Products and Services
10.8.4. Key Developments
10.9. Lantheus Medical Imaging, Inc.
10.9.1. Overview
10.9.2. Financials
10.9.3. Products and Services
10.9.4. Key Developments
10.10. Koninklijke Philips N.V
10.10.1. Overview
10.10.2. Financials
10.10.3. Products and Services
10.10.4. Key Developments
10.11. Digirad Corporation
10.11.1. Overview
10.11.2. Financials
10.11.3. Products and Services
10.11.4. Key Developments
List of Tables
List of Figures